STAAR Surgical Company

STAA Healthcare Medical Instruments & Supplies

In the quarter to June 2026, revenue grew 111.0%, EPS grew 147.1% and free cash flow grew 166.1%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

21.27 0.99 −4.45%
Market cap
$1.1B
P/E
304×
Fwd P/E
103×
Dividend yield
—
F-score
2/9
Altman Z
6.44
Beneish M
−3.29
Dividend safety
n/a
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
P/E ratio
0.00 0.00 66.07 64.06 155.54 677.09 113.45 306.53 0.00 0.00
Piotroski F-Score
2 3 3 6 7 5 6 7 7 4
P/S ratio
4.78 3.80 4.47 8.65 18.70 22.10 10.42 10.96 7.20 5.23
Altman Z-Score
6.44 7.43 10.30 18.44 30.96 36.81 20.47 23.81 13.71 7.26
Altman Z″-Score (non-manufacturers)
4.46 6.95 8.05 8.51 6.93 6.36 6.11 6.06 (2.93) (4.93)
P/FCF ratio
0.00 0.00 0.00 140.34 142.56 289.86 100.20 129.15 360.80 0.00
P/Operating CF
(292.42) 1,858.64 45.12 828.06 507.21 184.80 159.79 579.51 586.30 3,371.25
Beneish M-Score
(3.29) (3.06) (2.02) (1.91) (2.14) (2.59) (1.78) (2.38) (2.70) (3.46)
P/B ratio
3.33 3.00 3.74 7.32 16.67 18.32 9.79 10.26 15.18 11.38
Price to Tangible BV
3.34 3.02 3.76 7.36 16.80 18.51 9.92 10.42 15.95 12.11
EV/Sales
4.13 3.07 3.79 7.90 17.84 21.17 9.62 10.13 7.00 5.08
EV/EBITDA
0.00 0.00 39.78 47.71 111.16 350.81 92.93 138.60 0.00 0.00
EV/Operating CF
(28.91) 61.23 83.73 62.94 93.51 165.17 56.03 98.34 222.21 399.29
EV/FCF
(24.65) (124.20) (332.31) 128.28 135.97 277.63 92.54 119.32 350.84 (194.28)
Quick Ratio
3.47 4.39 4.85 5.30 4.98 4.55 4.38 4.68 1.91 1.44
Current Ratio
4.55 5.23 5.62 6.03 5.56 5.25 5.07 5.47 2.82 2.35
Net Debt/EBITDA
2.25 33.84 (7.18) (4.49) (5.39) (15.45) (7.69) (11.42) 64.94 1.30
Debt/Assets
0.00% 0.00% 0.01% 0.05% 0.11% 0.01% 0.18% 0.27% 0.78% 2.04%
Debt/Equity
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01 0.04
Asset Turnover
0.50 0.63 0.71 0.74 0.76 0.70 0.80 1.05 1.36 1.28
Operating CF/Net income
0.43 (0.78) 0.68 0.90 1.60 3.54 1.84 2.57 (1.33) (0.09)
Capex/Depreciation
(0.68) (4.03) (6.93) (5.47) (3.75) (2.72) (2.75) (0.91) (0.31) (1.11)
Interest Coverage
— — — 17.89 — 28.44 12.00 39.97 — —
ROE
(21.70%) (5.16%) 5.91% 13.34% 12.07% 3.31% 9.61% 5.67% (5.29%) (31.61%)
ROA
(16.74%) (4.05%) 4.70% 10.38% 9.12% 2.54% 7.50% 4.22% (3.21%) (18.89%)
ROIC
(36.59%) (4.72%) 10.63% 21.96% 35.18% 9.44% 18.39% 14.21% (9.10%) (31.33%)
Return on Tangible Assets
(25.43%) (5.28%) 5.82% 12.76% 10.64% 2.97% 8.93% 3.67% (4.80%) (30.14%)
Average Days of Receivables
76.32 90.58 107.21 80.15 68.94 78.67 75.33 76.40 71.92 72.37
Research and Development Expense of Revenue
16.73% 14.44% 12.55% 12.65% 14.69% 19.53% 16.84% 17.77% 22.12% 25.07%
Selling, General and Administrative Expense of Revenue
78.65% 65.90% 57.09% 50.49% 48.35% 48.74% 49.81% 50.73% 52.83% 61.09%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.01 0.01 0.01 0.01 0.03 0.03
Share Based Compensation of Revenue
12.77% 8.67% 7.29% 7.16% 6.34% 7.43% 7.02% 5.46% 3.49% 10.38%
Graham Net Nets
0.18 0.21 0.18 0.09 0.04 0.04 0.08 0.09 0.04 0.05
Graham Number
0.00 0.00 8.97 11.23 8.51 3.37 5.01 2.70 0.00 0.00
Earnings Yield
(7.06%) (1.69%) 1.51% 1.56% 0.64% 0.15% 0.88% 0.33% (0.27%) (2.71%)
Free Cash Flow Yield
(3.51%) (0.65%) (0.25%) 0.71% 0.70% 0.34% 1.00% 0.77% 0.28% (0.50%)
Revenue per Share
4.83 6.39 6.64 5.93 4.88 3.58 3.38 2.91 2.21 2.04
Operating CF per Share
(0.69) 0.32 0.30 0.74 0.93 0.46 0.58 0.30 0.07 0.03
Capex per Share
(0.12) (0.48) (0.37) (0.38) (0.29) (0.18) (0.23) (0.05) (0.03) (0.08)
Free Cash Flow per Share
(0.81) (0.16) (0.07) 0.37 0.64 0.28 0.35 0.25 0.04 (0.05)
Cash per Share
3.78 4.69 4.55 4.41 4.23 3.34 2.70 2.44 0.45 0.35
Shareholders Equity per Share
6.94 8.09 7.95 7.00 5.48 4.32 3.59 3.11 1.05 0.94
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
6.94 8.09 7.95 7.00 5.48 4.32 3.59 3.11 1.05 0.94
Free Cash Flow
(40.05) (7.67) (3.59) 17.61 30.32 12.55 15.62 10.52 1.81 (2.16)
Working Capital
243.04 297.63 300.23 260.01 222.61 175.18 140.19 123.84 34.80 28.45
Capital Expenditures
(5.82) (23.39) (18.19) (18.11) (13.64) (8.40) (10.18) (2.24) (1.05) (3.20)
Net Current Asset Value
204.05 255.75 262.53 229.02 184.19 156.22 127.03 116.66 28.89 21.95
EV/EBIT
0.00 0.00 43.49 51.32 123.31 511.21 121.94 190.38 0.00 0.00
Capex to Sales
0.02 0.07 0.06 0.06 0.06 0.05 0.07 0.02 0.01 0.04
Price to Operating Income
0.00 0.00 51.34 56.15 129.29 533.73 132.03 206.06 0.00 0.00
Other line items
Depreciation/Fixed assets
0.12 0.07 0.04 0.07 0.10 0.13 0.22 0.22 0.34 0.25
Cash ROIC
(7.53%) (1.22%) (0.59%) 3.21% 6.61% 3.59% 5.57% 4.44% 2.92% (4.05%)
Accounts Receivable Turnover
3.74 3.64 4.10 5.37 5.85 4.94 5.28 5.66 5.30 5.15
Accounts Payable Turnover
4.03 4.91 5.55 6.02 6.41 5.81 5.25 5.17 3.67 3.21
Inventory Turnover
1.15 1.90 2.35 2.94 2.93 2.56 2.26 2.16 1.87 1.57
Average Days of Payables
74.09 82.04 70.93 69.26 61.25 60.49 76.86 73.40 83.63 126.07
Days of Inventory on Hand
355.23 212.68 183.80 144.55 121.64 146.58 163.66 187.92 184.50 224.87
Average Receivables
63.98 86.30 78.58 52.99 39.38 33.11 28.47 21.90 17.10 16.01
Average Payables
14.14 15.13 12.57 10.14 8.09 7.76 7.29 6.28 7.17 7.50
Average Inventory
49.40 39.22 29.65 20.72 17.69 17.63 16.92 15.01 14.07 15.37
Average Assets
480.60 499.11 453.76 382.30 301.60 232.47 187.43 117.64 66.70 64.22
Average Common Equity
370.76 391.64 361.03 297.34 227.89 178.55 146.16 87.68 40.42 38.38

Fold the line items

Columns are period end dates